Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to fall 6.25% to -75 cents per share on August 19

Alto Neuroscience ANRO Stock Earnings Reports

Q2'26

Est.

$-0.75

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.20

Q3'25

Beat

by $0.12

Q2'25

Missed

by $0.05

The last earnings report on May 13 showed earnings per share of -80 cents, missing the estimate of -68 cents. With 63.50K shares outstanding, the current market capitalization sits at 804.70M.

View a ticker or compare two or three

Compare

ANRO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ANRO